Use of Cannabinoids in Pediatric Refractory Epilepsy Patients — with Dr. Evan Lewis: Avicanna's 4th Medical Symposium, Clinical Application, Session 3C

Avicanna’s 4th Medical Symposium – On Demand Session 3C: Use of Cannabinoids in Pediatric Refractory Epilepsy Dr. Evan Cole Lewis explores the role of cannabinoids in managing pediatric drug-resistant epilepsy. With current anti-seizure medications often falling short, this session examines emerging clinical evidence and real-world outcomes from a Canadian neurology clinic. Dr. Lewis reflects on the potential of cannabis to achieve seizure freedom and the broader implications for clinical practice, research, and policy. 🎓 Powered by Avicenna Academy | Presented by Avicanna

Course content

1 sections | 1 lessons